Literature DB >> 16575518

Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview.

Enrique Villar1, Isabel Muñoz Barroso.   

Abstract

Sialic acid-containing compounds play a key role in the initial steps of the paramyxovirus life cycle. As enveloped viruses, their entry into the host cell consists of two main events: binding to the host cell and membrane fusion. Virus adsorption occurs at the surface of the host cell with the recognition of specific receptor molecules located at the cell membrane by specific viral attachment proteins. The viral attachment protein present in some paramyxoviruses (Respirovirus, Rubulavirus and Avulavirus) is the HN glycoprotein, which binds to cellular sialic acid-containing molecules and exhibits sialidase and fusion promotion activities. Gangliosides of the gangliotetraose series bearing the sialic acid N-acetylneuraminic (Neu5Ac) on the terminal galactose attached in alpha2-3 linkage, such as GD1a, GT1b, and GQ1b, and neolacto-series gangliosides are the major receptors for Sendai virus. Much less is known about the receptors for other paramyxoviruses than for Sendai virus. Human parainfluenza viruses 1 and 3 preferentially recognize oligosaccharides containing N-acetyllactosaminoglycan branches with terminal Neu5Acalpha2-3Gal. In the case of Newcastle disease virus, has been reported the absence of a specific pattern of the gangliosides that interact with the virus. Additionally, several works have described the use of sialylated glycoproteins as paramyxovirus receptors. Accordingly, the design of specific sialic acid analogs to inhibit the sialidase and/or receptor binding activity of viral attachment proteins is an important antiviral strategy. In spite of all these data, the exact nature of paramyxovirus receptors, apart from their sialylated nature, and the mechanism(s) of viral attachment to the cell surface are poorly understood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575518     DOI: 10.1007/s10719-006-5433-0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  127 in total

Review 1.  Viruses: hostages to the cell.

Authors:  P Ghazal; J C González Armas; J J García-Ramírez; S Kurz; A Angulo
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

2.  Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.

Authors:  J P Langedijk; B L de Groot; H J Berendsen; J T van Oirschot
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

3.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  Effect of tunicamycin on the replication of Sendai virus.

Authors:  K Nakamura; M Homma; R W Compans
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

5.  Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion.

Authors:  Matteo Porotto; Matthew Murrell; Olga Greengard; Anne Moscona
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Endoproteolytic activation of Newcastle disease virus fusion proteins requires an intracellular acidic environment.

Authors:  T Yoshida; S Takao; K Kiyotani; T Sakaguchi
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

7.  Role of heparan sulfate in human parainfluenza virus type 3 infection.

Authors:  Santanu Bose; Amiya K Banerjee
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

8.  Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.

Authors:  A Moscona; R W Peluso
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Fusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperature-dependent defect in receptor binding.

Authors:  Elizabeth A Corey; Anne M Mirza; Elizabeth Levandowsky; Ronald M Iorio
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses.

Authors:  X L Hu; R Ray; R W Compans
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  58 in total

1.  A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.

Authors:  Anne Moscona; Matteo Porotto; Samantha Palmer; Caroline Tai; Lori Aschenbrenner; Gallen Triana-Baltzer; Qi-Xiang Li; David Wurtman; Stefan Niewiesk; Fang Fang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 2.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

3.  Complete genome characterisation of a Newcastle disease virus isolated during an outbreak in Sweden in 1997.

Authors:  Anna-Malin Linde; Muhammad Munir; Siamak Zohari; Karl Ståhl; Claudia Baule; Lena Renström; Mikael Berg
Journal:  Virus Genes       Date:  2010-07-17       Impact factor: 2.332

4.  A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion.

Authors:  Anuja Krishnan; Santosh K Verma; Prashant Mani; Rahul Gupta; Suman Kundu; Debi P Sarkar
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

5.  Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.

Authors:  Christine A Baumann; Wolfgang J Neubert
Journal:  Arch Virol       Date:  2009-12-19       Impact factor: 2.574

6.  Mechanism for active membrane fusion triggering by morbillivirus attachment protein.

Authors:  Nadine Ader; Melinda Brindley; Mislay Avila; Claes Örvell; Branka Horvat; Georg Hiltensperger; Jürgen Schneider-Schaulies; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Site-specific glycosylation of the Newcastle disease virus haemagglutinin-neuraminidase.

Authors:  Cassandra L Pegg; Christine Hoogland; Jeffrey J Gorman
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

Review 8.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

9.  A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein.

Authors:  Emma Herrera; Patricia Barcenas; Rubicela Hernández; Alfonso Méndez; Guillermo Pérez-Ishiwara; Blanca Barrón
Journal:  Virol J       Date:  2010-08-20       Impact factor: 4.099

10.  Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans.

Authors:  Joshua M DiNapoli; Jerrold M Ward; Lily Cheng; Lijuan Yang; Subbiah Elankumaran; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  Vaccine       Date:  2009-01-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.